By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Universal Ibogaine Inc.

Universal Ibogaine Inc. (IBOGF)

OTC Market Data in USD, Fundamentals in CAD
$0.01
$0.00
+3.51%
Last Update: 29 Aug 2025, 19:23
$3.08M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.10
52 Week Range

IBOGF Stock Price Chart

Explore Universal Ibogaine Inc. interactive price chart. Choose custom timeframes to analyze IBOGF price movements and trends.

IBOGF Company Profile

Discover essential business fundamentals and corporate details for Universal Ibogaine Inc. (IBOGF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 Mar 2022

Employees

CEO

Nicholas Peter Karos

Description

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.

IBOGF Financial Timeline

Browse a chronological timeline of Universal Ibogaine Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

IBOGF Stock Performance

Access detailed IBOGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run